These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1269 related items for PubMed ID: 15990019
1. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy. Chan TA, Weingart JD, Parisi M, Hughes MA, Olivi A, Borzillary S, Alahakone D, Detorie NA, Wharam MD, Kleinberg L. Int J Radiat Oncol Biol Phys; 2005 Jul 15; 62(4):1133-9. PubMed ID: 15990019 [Abstract] [Full Text] [Related]
2. GliaSite brachytherapy boost as part of initial treatment of glioblastoma multiforme: a retrospective multi-institutional pilot study. Welsh J, Sanan A, Gabayan AJ, Green SB, Lustig R, Burri S, Kwong E, Stea B. Int J Radiat Oncol Biol Phys; 2007 May 01; 68(1):159-65. PubMed ID: 17331666 [Abstract] [Full Text] [Related]
3. GliaSite brachytherapy for treatment of recurrent malignant gliomas: a retrospective multi-institutional analysis. Gabayan AJ, Green SB, Sanan A, Jenrette J, Schultz C, Papagikos M, Tatter SP, Patel A, Amin P, Lustig R, Bastin KT, Watson G, Burri S, Stea B. Neurosurgery; 2006 Apr 01; 58(4):701-9; discussion 701-9. PubMed ID: 16575334 [Abstract] [Full Text] [Related]
4. Imaging after GliaSite brachytherapy: prognostic MRI indicators of disease control and recurrence. Kleinberg L, Yoon G, Weingart JD, Parisi M, Olivi A, Detorie NA, Chan TA. Int J Radiat Oncol Biol Phys; 2009 Dec 01; 75(5):1385-91. PubMed ID: 19394153 [Abstract] [Full Text] [Related]
8. Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article. Marina O, Suh JH, Reddy CA, Barnett GH, Vogelbaum MA, Peereboom DM, Stevens GH, Elinzano H, Chao ST. J Neurosurg; 2011 Aug 01; 115(2):220-9. PubMed ID: 21548745 [Abstract] [Full Text] [Related]
9. An inflatable balloon catheter and liquid 125I radiation source (GliaSite Radiation Therapy System) for treatment of recurrent malignant glioma: multicenter safety and feasibility trial. Tatter SB, Shaw EG, Rosenblum ML, Karvelis KC, Kleinberg L, Weingart J, Olson JJ, Crocker IR, Brem S, Pearlman JL, Fisher JD, Carson K, Grossman SA, New Approaches to Brain Tumor Therapy Central Nervous System Consortium. J Neurosurg; 2003 Aug 01; 99(2):297-303. PubMed ID: 12924704 [Abstract] [Full Text] [Related]
13. Experiences with reoperation on recurrent glioblastoma multiforme. Pinsker M, Lumenta C. Zentralbl Neurochir; 2001 Nov 15; 62(2):43-7. PubMed ID: 11786935 [Abstract] [Full Text] [Related]
14. Longitudinal magnetic resonance imaging features of glioblastoma multiforme treated with radiotherapy with or without brachytherapy. Aiken AH, Chang SM, Larson D, Butowski N, Cha S. Int J Radiat Oncol Biol Phys; 2008 Dec 01; 72(5):1340-6. PubMed ID: 18538496 [Abstract] [Full Text] [Related]
15. Epidermal growth factor receptor amplification does not have prognostic significance in patients with glioblastoma multiforme. Quan AL, Barnett GH, Lee SY, Vogelbaum MA, Toms SA, Staugaitis SM, Prayson RA, Peereboom DM, Stevens GH, Cohen BH, Suh JH. Int J Radiat Oncol Biol Phys; 2005 Nov 01; 63(3):695-703. PubMed ID: 15936158 [Abstract] [Full Text] [Related]
16. Hypofractionated intensity-modulated radiotherapy for primary glioblastoma multiforme. Floyd NS, Woo SY, Teh BS, Prado C, Mai WY, Trask T, Gildenberg PL, Holoye P, Augspurger ME, Carpenter LS, Lu HH, Chiu JK, Grant WH, Butler EB. Int J Radiat Oncol Biol Phys; 2004 Mar 01; 58(3):721-6. PubMed ID: 14967426 [Abstract] [Full Text] [Related]
17. Short course of radiation therapy in elderly patients with glioblastoma multiforme. Idbaih A, Taillibert S, Simon JM, Psimaras D, Schneble HM, Lopez S, Lang P, Toubiana T, Feuvret L, Delattre JY, Mazeron JJ. Cancer Radiother; 2008 Dec 01; 12(8):788-92. PubMed ID: 19046921 [Abstract] [Full Text] [Related]